Matthew A. Spear - Chief Medical Officer at Poseida Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
PSTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew A. Spear since 9/17/2023

Holdings reported by Matthew A. Spear for Poseida Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 111K $596K $5.35 Mar 1, 2022 Direct
Employee Stock Option (Right to Buy) 72.6K Mar 1, 2022 Direct Common Stock

Transactions reported by Matthew A. Spear for Poseida Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.